Research Article
[Retracted] PTPN18 Stimulates the Development of Ovarian Cancer by Activating the PI3K/AKT Signaling
Table 1
Clinicopathologic characteristics of the enrolled patients with ovarian cancer in low and high PTPN18 groups.
| Indexes | N | PTPN18 | P | Low (n = 24) | High (n = 20) |
| Age (y) | 0.956 | <60 | 20 | 11 | 9 | | ≥60 | 24 | 13 | 11 | | T staging | 0.047 | T1/T2 | 26 | 17 | 9 | | T3/T4 | 18 | 7 | 11 | | Lymph node metastasis | 0.040 | No | 25 | 17 | 8 | | Yes | 19 | 7 | 12 | | Distance metastasis | 0.019 | No | 28 | 19 | 9 | | Yes | 16 | 5 | 11 | |
|
|